Arkolith/Insider Trading/RIGL/Form 4

Schorno Dean L

EVP & Chief Financial OfficerRIGEL PHARMACEUTICALS INC (RIGL) · full profile →Form 4 · filed Dec 29, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2025Option exercise(M)2K$18.70$31K64K
Dec 22, 2025Option exercise(M)3K$24.20$69K63K
Dec 22, 2025Option exercise(M)2K$20.00$40K60K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 22, 2025Option exercise(M)2K—$014K
Dec 22, 2025Option exercise(M)3K—$017K
Dec 22, 2025Option exercise(M)2K—$011K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-004492) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML